A clinical trial of dextromethorphan in amyotrophic lateral sclerosis
Introduction - Although the cause of amyotrophic lateral sclerosis (ALS) is unknown, excitotoxicity mediated by glutamate has been implicated. Dextromethorphan is a NMDA-glutamate receptor antagonist with neuroprotective properties. Material and methods - The effect of treatment with dextromethorpha...
Guardat en:
Autors principals: | , , , , , , , , , |
---|---|
Format: | Artigo |
Idioma: | anglès |
Publicat: |
2009
|
Accés en línia: | https://doi.org/10.1111/j.1600-0404.1997.tb00231.x |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|